Effects of Hemp-Derived Cannabinoids on Menopause Symptoms
Washington State University
Summary
The purpose of the study is to examine the impact of hemp-derived minor cannabinoids on symptoms of menopause/perimenopause.
Description
This study implements a randomized, double-blind, placebo-controlled, observational field experiment design to examine the impact of hemp-derived cannabinoids on symptoms of menopause/perimenopause. The study will require 3 months to complete. Healthy adult women (between the ages of 40-60) experiencing psychological and physical symptoms of menopause or perimenopause will be recruited via advertisements on social media, physicians' offices, in the community, at menopause conferences/conventions, and on internet forums. Prospective participants will complete a brief online screening survey to…
Eligibility
- Age range
- 40–60 years
- Sex
- Female
- Healthy volunteers
- Yes
Inclusion Criteria: * designated female at birth * 40-60 years of age * able to give informed consent (no intellectual disability) * stable pharmacotherapeutic regimen, no change in the past 3 months * abstinent from regular cannabis use (\<1x/month) for past year, and willing to abstain from use for 3 months * abstinent for supplements, don't add any supplements (no changes in past 3 months) * own a smartphone * have access to Zoom on a secure, stable internet connection * perimenopausal or menopausal Exclusion Criteria: * currently taking anti-depressant, anti-anxiety, and/or antipsychoti…
Interventions
- DrugHemp-derived cannabinoids
Participants will be administered a legal product with hemp-derived cannabinoids and terpenes.
- DrugPlacebo
Participants will be administered a placebo
Location
- Washington State University, Dept of PsychologyPullman, Washington